This company has been marked as potentially delisted and may not be actively trading. NYSE:CRY CryoLife (CRY) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About CryoLife Stock (NYSE:CRY) 30 days 90 days 365 days Advanced Chart Get CryoLife alerts:Sign Up Key Stats Today's Range N/A50-Day Range$17.19▼$21.7252-Week Range N/AVolume7,792 shsAverage Volume198,221 shsMarket Capitalization$703.22 millionP/E Ratio596.20Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview CryoLife, Inc. engages in the manufacture, process and distribution of medical devices and implantable human tissues. It operates through the Medical Devices and Preservation Services segments. The Medical Devices segment includes revenues from sales of BioGlue products, aortic stents and stent grafts, On-X products, CardioGenesis cardiac laser therapy, PerClot, and PhotoFix. The Preservation Services segment focuses on revenues from preservation of cardiac and vascular implantable human tissues. The company was founded on January 19, 1984 and is headquartered in Kennesaw, GA. Read More CryoLife Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks26th Percentile Overall ScoreCRY MarketRank™: CryoLife scored higher than 26% of companies evaluated by MarketBeat, and ranked 818th out of 943 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for CryoLife. Earnings and Valuation1.9 / 5Proj. Earnings Growth600.00% Earnings GrowthEarnings for CryoLife are expected to grow by 600.00% in the coming year, from $0.03 to $0.21 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of CryoLife is 596.20, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 26.50.Price to Earnings Ratio vs. SectorThe P/E ratio of CryoLife is 596.20, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.06. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for CRY. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCryoLife does not currently pay a dividend.Dividend GrowthCryoLife does not have a long track record of dividend growth. Sustainability and ESG3.7 / 5Environmental Score-1.53 Short InterestThere is no current short interest data available for CRY. News and Social Media0.6 / 5News SentimentN/A Search Interest1 people have searched for CRY on MarketBeat in the last 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, CryoLife insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 4.50% of the stock of CryoLife is held by insiders.Percentage Held by Institutions81.57% of the stock of CryoLife is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about CryoLife's insider trading history. Receive CRY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CryoLife and its competitors with MarketBeat's FREE daily newsletter. Email Address CRY Stock News Headlines1 Profitable Stock to Target This Week and 2 to Steer Clear OfApril 24, 2025 | msn.comCryoLife Stock Soars to 52-Week High, Hits $30.62January 16, 2025 | msn.comI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before the open. That’s the kind of move Tim Sykes built his XGPT system to trade. It scans AI news in real time, filters the noise, and pinpoints when to strike. He’s now showing exactly how it works — before the next headline hits.July 18 at 2:00 AM | Timothy Sykes (Ad)US medical device giant Artivion says hackers stole files during cybersecurity incidentDecember 10, 2024 | finance.yahoo.comJudith Jamison, acclaimed Alvin Ailey American dancer and director, dead at 81November 11, 2024 | usatoday.comArtivion price target raised to $35 from $32 at Lake StreetNovember 10, 2024 | markets.businessinsider.comJudith Jamison, Alvin Ailey Dancer of ‘Power and Radiance,’ Dies at 81November 10, 2024 | nytimes.comArtivion (AORT) Receives a Buy from Lake StreetNovember 5, 2024 | markets.businessinsider.comSee More Headlines CRY Stock Analysis - Frequently Asked Questions How were CryoLife's earnings last quarter? CryoLife, Inc. (NYSE:CRY) announced its earnings results on Thursday, November, 4th. The medical equipment provider reported $0.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.22. The medical equipment provider earned $72.21 million during the quarter, compared to analyst estimates of $72.90 million. CryoLife had a trailing twelve-month return on equity of 4.24% and a net margin of 0.63%. Does CryoLife have any subsidiaries? CryoLife subsidiaries include JOTEC AG, On-X Life Technologies Inc., Hemosphere, Cardiogenesis Corporation, AuraZyme Pharmaceuticals Inc., CryoLife Asia Pacific PTE. Ltd., CryoLife Canada Inc., and others. What other stocks do shareholders of CryoLife own? Based on aggregate information from My MarketBeat watchlists, some other companies that CryoLife investors own include Energy Transfer (ET), Johnson & Johnson (JNJ), AT&T (T), Meta Platforms (META), Gilead Sciences (GILD), International Business Machines (IBM) and Netflix (NFLX). Company Calendar Last Earnings11/04/2021Today7/18/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical & Medical Instruments Sub-IndustryHealth Care Equipment Current SymbolNYSE:CRY CIK784199 Webwww.cryolife.com Phone(770) 419-3355Fax770-426-0031Employees1,200Year Founded1984Profitability EPS (Trailing Twelve Months)$0.03 Trailing P/E Ratio596.20 Forward P/E RatioN/A P/E GrowthN/ANet Income-$16.68 million Net Margins0.63% Pretax Margin0.41% Return on Equity4.24% Return on Assets1.63% Debt Debt-to-Equity Ratio0.99 Current Ratio4.21 Quick Ratio2.93 Sales & Book Value Annual Sales$253.23 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow23.30 Book Value$8.46 per share Price / BookN/AMiscellaneous Outstanding Shares39,330,000Free Float37,560,000Market Cap$703.22 million OptionableOptionable Beta1.53 Social Links Elon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free Report This page (NYSE:CRY) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTurn $1K into $50K with This DeFi GemTHREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | Sponsored“All the land that you see I will give to you and your offspring forever…”“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CryoLife, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CryoLife With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.